慢跑 发表于 2025-3-25 06:34:58

Submitted on: 14 September 2010.
Revised on: 20 December 2010.
Accepted on: 03 January 2011.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

consolidate 发表于 2025-3-25 10:24:32

http://reply.papertrans.cn/1/38/3722/3722-22.png

Entrancing 发表于 2025-3-25 14:49:24

Submitted on: 07 July 2014.
Revised on: 15 August 2014.
Accepted on: 12 September 2014.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

表被动 发表于 2025-3-25 16:04:30

http://reply.papertrans.cn/1/38/3722/3722-24.png

GENRE 发表于 2025-3-25 21:01:24

http://reply.papertrans.cn/1/38/3722/3722-25.png

generic 发表于 2025-3-26 03:03:27

Submitted on: 18 March 2024.
Revised on: 31 May 2024.
Accepted on: 25 July 2024.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

小臼 发表于 2025-3-26 05:17:00

http://reply.papertrans.cn/1/38/3722/3722-27.png

Defiance 发表于 2025-3-26 10:46:01

Submitted on: 31 January 2017.
Revised on: 04 April 2017.
Accepted on: 13 May 2017.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

Urologist 发表于 2025-3-26 14:07:54

Submitted on: 24 December 2021.
Revised on: 31 March 2022.
Accepted on: 28 April 2022.

___________________BIOPHARM INTERNATIONAL---ADVANSTAR COMMUNICATIONS INC

Colonoscopy 发表于 2025-3-26 20:00:32

http://reply.papertrans.cn/1/38/3722/3722-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊BIOPHARM INTERNATIONAL 2024/2025影响因子:0.114 (BIOPHARM INT) (1542-166X). (BIOTECHNOLOGY & APPLIED MICROBIOLOGY)(生物技